LEGACY IIII Network Launch in Liverpool

Legacy IIII group photo

 

 

 

 

 

 

 

 

 

 

1st December 2025 Sarah, Angela and Simon attended the LEGACY IIII Network Launch in Liverpool (and online). LEGACY IIII stands for: Lymph nodE single-cell Genomics AnCestrY immunity, infection, inflammation and immunisation. This network, co-led by Kat Pollock, Lucy Jones and John Isaacs and funded by Medical Research Council (MRC), aims to connect 10 specialist centres across the UK to transform lymph-node human immunology research by generating transformative, open-science resources to accelerate discoveries across infection, vaccination, inflammation and immune-mediated disease.

Major investment puts UK universities at the forefront of groundbreaking lymph node research — Oxford Vaccine Group